Completed NCT04524403
This study is completed in the United States. It focuses on schizophrenia.
In United States Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Corcept Therapeutics
Condition Schizophrenia Completed NCT02947308
This summary needs review. Please check the official study record and contact the research team for details.
In United States Suicidality Observational i A study where researchers collect information without assigning a treatment. From 12 Years to 16 Years
Countries United States
Sponsor University of Minnesota
Condition Suicidality Completed NCT00844857
This summary needs review. Please check the official study record and contact the research team for details.
In United States Bipolarity, Depression Drug From 10 Years to 17 Years
Countries United States, Russia
Sponsor Eli Lilly and Company
Condition Bipolarity, Depression Completed NCT00195780
This summary needs review. Please check the official study record and contact the research team for details.
In United States Bipolarity Drug From 10 Years to 17 Years
Countries United States
Sponsor Abbott
Condition Bipolarity Completed NCT05841030
This study is completed in the United States, in France, in Canada, .... It focuses on depression.
In United States Depression Observational From 18 Years to 74 Years
Countries United States, France, Canada, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Unknown NCT03642964
This summary needs review. Please check the official study record and contact the research team for details.
In United States Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Chase Therapeutics Corporation
Condition Depression Completed NCT01606436
This study is completed in the United States. It focuses on schizophrenia.
In United States Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Denovo Biopharma LLC
Condition Schizophrenia Completed NCT06051721
This study is completed in the United States. It is testing N, N-dimethyltryptamine (DMT) Analog for anxiety.
In United States Anxiety Behavioral From 18 Years to 65 Years
Countries United States
Sponsor Cybin IRL Limited
Condition Anxiety Completed NCT00095758
This study is completed in the United States. It is testing aripiprazole for depression.
In United States Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Depression Completed NCT00567203
This study is completed in the United States. It is testing treatment Of Cognitive Deficits for schizophrenia.
In United States Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Pfizer
Condition Schizophrenia Completed NCT02634346
This study is completed in the United States, in Bulgaria, in Serbia, .... It is testing ALKS 3831 for schizophrenia.
In United States Schizophrenia Drug From 18 Years to 70 Years
Countries United States, Bulgaria, Serbia, ...
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT01903837
This study is completed in the United States, in Bulgaria, and in Czechia. It is testing ALKS 3831 for schizophrenia.
In United States Schizophrenia Drug From 18 Years to 50 Years
Countries United States, Bulgaria, Czechia
Sponsor Alkermes, Inc.
Condition Schizophrenia